ClinicalTrials.Veeva

Menu

The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients

M

Methodist Health System

Status

Completed

Conditions

Infection in Solid Organ Transplant Recipients

Treatments

Procedure: Solid organ transplant

Study type

Observational

Funder types

Other

Identifiers

NCT04637321
059.PHA.2019.D

Details and patient eligibility

About

2.1. Study Objectives

  • Primary Objective(s)
  • Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant
  • Secondary Objective(s)
  • Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant
  • Evaluate the impact of CDI on graft survival following Solid Organ Transplant

Full description

  • Single center, retrospective cohort chart review study design
  • Data will be collected on all liver, kidney, pancreas and combined transplant recipients who received their graft(s) from April 1, 2015 to July 31, 2018
  • Will analyze outcomes from April 1, 2014 to July 31, 2019
  • Patient list will be generated in Epic and Meditech
  • All data will be obtained from Epic and Meditech
  • All data will be collected retrospectively after the patient is discharged from the hospital

Enrollment

585 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Solid organ transplant patients who received graft(s) at MDMC from April 1, 2015 to July 31, 2018
  • Age >18 years old

Exclusion criteria

  • Age <18 years old
  • Loss to early death defined as within one week from transplantation
  • Patients whose primary address is in Puerto Rico

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems